Company profile
Laboratorios Farmacéuticos Rovi, S.A.
small molecule and specialty biologics; injectable/prefilled-syringe CDMO
ROVI · BME · Madrid, Spain
Public Market Listing
ROVIBME
Live quotes, historical charts, and market capitalization for Laboratorios Farmacéuticos Rovi, S.A. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
1Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule | Schizophrenia | |
| Phase 3 | Dopamine D2 and serotonin 5-HT2 receptors (antagonist) · Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule | Schizophrenia |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.